Search the Newsreel

Elicio Therapeutics (ELTX) awards 60,833 stock options to its CFO

Elicio Therapeutics, Inc. (ELTX) has granted its Chief Strategy and Financial Officer, Preetam Shah, 60,833 stock options at an exercise price of $3.20 per share, as detailed in a Form 4 SEC filing. These options expire on July 16, 2036, and will vest in …

Elicio Therapeutics (ELTX) awards 64,643 stock options to R&D and medical chief

Elicio Therapeutics (ELTX) has granted 64,643 stock options to Christopher Haqq, Executive Vice President, Head of R&D, and Chief Medical Officer. The options have an exercise price of $3.20 per share, expire on July 16, 2036, and vest in two 50% tranches on July …

Elicio Therapeutics (ELTX) grants 52,832 stock options to Chief Scientific Officer

Elicio Therapeutics, Inc. (ELTX) has granted 52,832 stock options to its Chief Scientific Officer, Peter DeMuth. The options have an exercise price of $3.20 per share and will expire on July 16, 2036. The shares will vest in two equal installments, 50% on July …

Elicio Therapeutics (ELTX) CEO awarded 186,944 stock options at 3.2000

Elicio Therapeutics (ELTX) CEO, President, and Director Robert Connelly was granted 186,944 stock options at an exercise price of $3.20 per share on July 16, 2026. These options expire on July 16, 2036, and vest in two equal tranches on July 16, 2027, and …

Moti Investments discloses 6.1% stake in Elicio Therapeutics (NASDAQ: ELTX)

Moti Investments LLC has disclosed a 6.1% stake in Elicio Therapeutics, owning 1,408,892 shares of common stock, as reported in a Schedule 13G filing. The investment firm, organized in Saint Kitts and Nevis and based in Dubai, holds sole voting and dispositive power over …

ELTX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Clinical Development - Earnings Power Value

ELTX Forecast — Price Target — Prediction for 2027

Elicio Therapeutics (ELTX) Drops 4.14% as Bearish Momentum Tests Key Support - Quality ETF

Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Price, News & Analysis

Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX)

Global Vectra Helicorp faces fines for board non-compliance

Elicio Therapeutics, Inc. 1Q 2026: Net income $(11.8M), EPS $(0.65) — 10-Q Summary

Global Vectra Helicorp Clarifies Share Price Movement to Stock Exchanges

A Look At WEILONG Delicious Global Holdings (SEHK:9985) Valuation After Strong Full Year 2025 Results

Is Elicio Therapeutics (NASDAQ:ELTX) Using Debt In A Risky Way?

While insiders own 33% of Elicio Therapeutics, Inc. (NASDAQ:ELTX), individual investors are its largest shareholders with 55% ownership

Global Vectra Helicorp Reports Widening Losses in Q2 FY2026

Global Vectra Stock Soars 20% as Ace Investor Vijay Kedia Increases Stake

Vijay Kedia portfolio: Ace investor raises stake in Global Vectra, makes fresh entry in this small-cap stock in Q2

Elicio Therapeutics (ELTX) Stock Price, News & Analysis

GLOBALVECT Share Price Today - Global Vectra Helicorp on NSE/BSE

Elicio Therapeutics Inc. (ELTX) Live Share Price, Invest From India

Vijay Kedia trims stake in Global Vectra in March quarter. Here’s how this smallcap stock has performed

WL Delicious Announced 2024 Annual Results

Global Vectra Helicorp Share Price Target 2026, 2027, 2030, 2040, 2050

Chinese spicy snacks giant Weilong sees first-half profit rise amid slow economy

Global Vectra Helicorp: Vijay Kedia raises stake in this multibagger stock by 1.9%, now holds 4.9%

Vijay Kedia portfolio: Multibagger stock Global Vectra hits lifetime high despite stock market crash today

Edil San Felice S.p.A.: azionisti, dirigenti e profilo società | ESF | IT0005561441

WEILONG Delicious Global Holdings Ltd (9985.HK) stock price, news, quote and history

Elicio Therapeutics, Inc. (ELTX) Stock Price, News, Quote & History